| Description: Highly crystalline homopolymer phase, very high molecular weight EPR phase, very high flexural modulus, reduced emissions, reduced gels. Applications: Suggested uses include compounding. Process: Compounding. This resin meets the requirements for olefin polymers as defined in 21 CFR, section 177.1520 issued by FDA – Food and Drugs Administration. The additives present are covered in appropriate regulation by FDA Information provided by Braskem |
